Heterotopic pancreas in excluded stomach diagnosed after gastric bypass surgery
- 3.8k Downloads
Heterotopic pancreas is defined as finding of pancreatic tissue without anatomic and vascular continuity with the normal pancreas. Heterotopic pancreas is a rare condition difficult to diagnose and with controversial clinical management.
We describe a 43 year old female patient previously submitted to laparoscopic gastric bypass for primary treatment of morbid obesity; 5 years later, the patient was discovered to have a mass in the antrum of the excluded stomach that was found to be heterotopic pancreatic tissue. Before gastric bypass surgery, the presence of the pancreatic mass in the gastric wall was unnoticed in the imagiologic records.
This is the first reported case of pancreatic heterotopy diagnosed in the excluded stomach after gastric bypass. A putative role of incretin hormones in mediating pancreatic cell hyperplasia of heterotopic pancreatic remnants should be considered an additional hypothesis that requires further research.
KeywordsHeterotopic pancreas Gastric bypass Excluded stomach Incretins
Gastrointestinal autonomic nerve tumor
Gastrointestinal stromal tumor
Magnetic resonance Imaging.
Heterotopic pancreas was first described in 1727 by Schultz and is defined as the presence of pancreatic tissue whithout anatomic and vascular continuity with the normal pancreas . It is found in 0.55-15% of autopsy specimens  being more common at the age of 30–50 years with a male predominance . The heterotopic tissue can be found anywhere from the distal end of the esophagus to the colon, but mostly occurs in upper gastrointestinal tract: stomach(25%), duodenum(30%) and jejunum(15%), but also in liver, gallbladder, distal small intestine, colon, appendix, omentum, fallopian tube, common bile duct, cystic duct, ampulla of Vater, spleen, lymph nodes and Meckel’s diverticula. Extra-abdominal sites included mediastinal cysts, bronchi, lung, umbilicus and brain [4, 5, 6, 7, 8]. The most common heterotopic site is the stomach (25-40%), especially antrum and prepyloric region on the greater curvature or posterior wall .
Heterotopic pancreas is thought to take place when the foregut rotates between weeks 5 and 8 of gestation, while pancreatic fragments detach from the pancreas and are deposited ectopically . Heterotopic pancreatic tissue in the gastro-intestinal tract generally occurs as discrete firm, irregular, yellow nodules located in the submucosa. Histologically heterotopic pancreatic tissue is not a true neoplasm but rather a hamartoma of fat glandular tissue with pancreatic acinar formation and duct development . In the majority of cases the patients are asymptomatic and the condition is incidentally discovered . Almost all changes which can occur in the pancreas itself may develop in heterotopic pancreas , although malignant transformation is extremely rare .
There are several cases of heterotopic pancreases described in the literature, but to date none of them was diagnosed in the excluded stomach after gastric bypass.
A 43 years old female patient was previously submitted to laparoscopic gastric bypass for morbid obesity without co-morbidities. Seven months after the bariatric surgery the patient showed intense episodic epigastric abdominal pain that was aggravated by food ingestion and led to multiple visits to the emergency room.
Five years after gastric bypass, due to ongoing epigastric pain complaints, abdominal CT and MRI were repeated, with subsequent diagnosis of a 4.5 cm of greater diameter subserosal neoplasm in the antrum (Figure 1B).
Most patients with heterotopic pancreas are asymptomatic; when present, the reported symptoms include abdominal pain, epigastric discomfort, bleeding, nausea and vomiting; sometimes symptoms are related to complications, such as mechanical occlusion - intussusceptions and obstruction of the small bowel, obstructive jaundice and pyloric stenosis [8, 13]. Other complications include: pancreatitis, pseudocyst formation, carcinomas, islet-cell tumors and inflammatory pseudotumors . Most cases of gastric heterotopic pancreas are incidental findings during surgery, gastrointestinal exam or autopsy.
The differential diagnosis includes GIST, gastrointestinal autonomic nerve tumor (GANT), carcinoid, lymphoma or gastric carcinoma which can be misinterpreted on imaging studies or endoscopic examinations [14, 15].
Since heterotopic pancreas is an uncommon condition, unlike GIST, it is rarely considered a diagnostic hypothesis. Five CT features were pointed as significant predictors in the differential diagnosis of heterotopic pancreas from GIST and leiomyomas, namely: 1) prominent enhancement of the overlying mucosa, 2) location, 3) long diameter/short diameter ratio of the lesion, 4) growth pattern and 5) lesion border . At endoscopy the heterotopic pancreas generally appears as a well-defined dome-shaped filling defect with central umbilication. Definitive diagnosis requires histological confirmation.
Management of this condition is controversial. Most cases undergo surgery due to diagnostic uncertainty. Reasons for surgical treatment depend on the presence of symptoms, as well as need of definitive diagnosis, excluding malignancy or avoiding complications .
This patient had both normal abdominal ultrasound and gastroduodenoscopy before gastric bypass¸ and the presence of a mass in the excluded stomach had been unnoticed in the abdominal CT and MRI performed four years before gastrectomy. In the herein case presented, GIST of the excluded stomach was the first diagnostic hypothesis, due to the previous history of gastric bypass, endoscopic ultra-sound (EUS) could not be useful.
There was no evidence of acute pancreatitis in any recurrency of episodic abdominal pain that lead patient to visit the emergency room, as suggested from serum amylase and lipase levels, however, since the heterotopic pancreas included a cystic cavity with a thick liquid content, the formation of a cyst in result of retention of exocrine secretions in the absence of communication between the glandular epithelium and the gastric lumen cannot be excluded.
Gastric bypass is known to induce changes in the secretion of insulinotropic enteric hormones, which may be involved in metabolic changes, remission of diabetes mellitus [18, 19] and have a role in inducing pancreatic exocrine and endocrine cell proliferation . Thus, it is conceivable that microscopic heterotopic nodules of pancreatic tissue can grow in result of gastric bypass surgery, similarly to what has been hypothesized to occur with regards to orthotic pancreatic tissue. Notwithstanding, the action of incretin hormones in stimulation the growth of pancreatic tissue still needs further research.
Heterotopic pancreas is a rare condition, difficult to diagnose and with controversial management. We present the first case of pancreatic heterotopy diagnosed after gastric bypass surgery. The role of incretin hormones in stimulating the growth of pancreatic cells and its consequences justifies further investigation.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
The authors acknowledge the contributions of Madalena Costa, Sofia Pereira and Tiago Morais ICBAS-UP, for technical support with histology and immunohistochemistry of the pancreatic tissue as well as picture art work. UMIB is funded by grants from FCT POCTI/FEDERFcomp-01-0124-FEDER-015893.
- 2.Hill I, Lebenthal E: Congenital abnormalities of the exocrine pancreas. The Pancreas: Biology, Pathobiology and Disease. 1993, New York: Raven, 1029-1040.Google Scholar
- 10.Seifert G: Congenital anomalies. Pancreatic pathology. Edited by: Klöppel G, Heitz PU. 1984, London: Churchill Livingstone, 69-94.Google Scholar
- 18.Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR: Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond). 2010, 34 (3): 462-471. 10.1038/ijo.2009.254.CrossRefGoogle Scholar
- 20.Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC: Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes. 2013, 62 (7): 2595-2604. 10.2337/db12-1686.CrossRefPubMedPubMedCentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2482/13/56/prepub
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.